rocuronium and Hypersensitivity

rocuronium has been researched along with Hypersensitivity* in 2 studies

Other Studies

2 other study(ies) available for rocuronium and Hypersensitivity

ArticleYear
Does Sugammadex Suppress Allergic Inflammation Due to Rocuronium in Animal Model of Rat?
    Allergologia et immunopathologia, 2021, Volume: 49, Issue:3

    There are a few reports in the literature about the successful use of sugammadex in the treatment of hypersensitivity reactions caused by rocuronium; however, the pathophysiological mechanism is still unknown. This study aims to investigate the changes caused by rocuronium in the lung and the effect of sugammadex on these changes with biochemical, light microscopic and immunohistochemical parameters on a rat model.. For the study, 28-male Sprague-Dawley rats were randomly divided, seven of each, into four groups. Group C (control) received only 0. 9 % NaCl without any drug. Group R received rocuronium alone 1mg/kg. Group S received sugammadex alone 96 mg/kg. Group RS received rocuronium 1mg/kg and sugammadex 96 mg/kg. After 24 h later, the animals were sacrificed and their tissues were removed. Biochemical (IgE/CRP), light microscopic and immunohistochemical findings were recorded.. Immunoglobulin E and CRP levels, peribronchial, alveolar septal lymphocytic infiltration, thickening of the alveolar membranes and bleeding sites in Group R were significantly higher than all the other groups. In Group RS, while these parameters were significantly lower than that of Group R and Group S, it was significantly higher than that of Group C. Total mast cells and tryptase-positive mast cells counts were significantly higher in Group R than in all other groups. In Group RS, these parameters were statistically lower than that of Group R and Group S, but higher than that of Group C.. This study shows that allergic inflammatory changes due to rocuronium in the lungs of rats are reduced with sugammadex. These results support cases of anaphylaxis due to rocuronium which improved with sugammadex.

    Topics: Anaphylaxis; Animals; C-Reactive Protein; Disease Models, Animal; Hemorrhage; Hypersensitivity; Immunoglobulin E; Inflammation; Lung; Lymphocytes; Male; Mast Cells; Neuromuscular Nondepolarizing Agents; Pulmonary Alveoli; Random Allocation; Rats; Rats, Sprague-Dawley; Rocuronium; Sugammadex; Tryptases

2021
Allergy to rocuronium: from clinical suspicion to correct diagnosis.
    Allergy, 2011, Volume: 66, Issue:8

    Allergy to rocuronium can be life-threatening. Correct diagnosis is a prerequisite because of serious consequences of diagnostic error.. To assess skin testing, quantification of specific IgE (sIgE) and flow-assisted activation of basophils [basophil activation test (BAT)] in the diagnosis of rocuronium allergy.. This study comprises 104 curarized patients with a history of profound hypotension and severe bronchospasm immediately after induction of anaesthesia. All patients had skin tests, quantification of sIgE and BAT to rocuronium, together with investigations for all relevant compounds administered during anaesthesia that could have evoked the reaction. Diagnosis of rocuronium allergy was considered definite when the patient demonstrated a positive outcome for at least two of the three aforementioned tests.. The positive predictive value for skin testing, BAT and sIgE was 98% (CI 95%: 92-99%), 97% (CI 95%: 88-100%) and 83% (CI 95%: 74-89%), respectively. The negative predictive value for skin testing, BAT and sIgE was 96% (CI 95%: 86-99%), 75% (CI 95%: 67-75%) and 72% (CI 95%: 58-83%), respectively. Cross-reactivity with vecuronium was documented in 69% of the patients.. Skin testing merits the status of primary diagnostic investigation to document rocuronium allergy and cannot be substituted by quantification of sIgE or BAT. SIgE can offer a diagnostic advantage in cases where skin tests yield negative results. However, additional tests (e.g. BAT) are of capital importance in patients with negative skin tests and positive sIgE results to help in interpreting the clinical significance of a positive sIgE result. Optimal assessment of cross-reactivity between rocuronium and vecuronium implies both skin testing and BAT.

    Topics: Adolescent; Adult; Aged; Androstanols; Basophils; Drug Hypersensitivity; Female; Humans; Hypersensitivity; Immunoglobulin E; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Predictive Value of Tests; Prospective Studies; Rocuronium; Skin Tests; Vecuronium Bromide; Young Adult

2011